

PDE5 inhibitor with the longest active window on market. Daily low-dose removes the timing problem. Every intake cleared by a licensed provider.
Tadalafil is a long-acting PDE5 inhibitor with a plasma half-life of ~17.5 hours, producing a clinical window of 24-36 hours. RCT response rates sit at 70-80% for organic ED; daily low-dose (2.5-5 mg) is validated for both ED and BPH. Provider review clears cardiovascular status, nitrate use, alpha-blocker overlap, and hepatic function before dispensing.
Daily dosing: take one tablet at the same time each day. On-demand: take 30-60 minutes before activity as directed by your provider. Do not exceed the prescribed daily amount.
Subscribe & Save
Cancel anytime
$2/mo
One-time
After provider review
$3
Related reading
Men's Health
Low T is rarely the whole answer. Thyroid, sleep, iron, lipids, and training load shape the outcome before testosterone does.
ReadSildenafil vs tadalafil: which PDE5 inhibitor fits your life
Both are PDE5 inhibitors with roughly the same response rate. The difference is the clock. Sildenafil is a short window on-demand option; tadalafil either...
ReadClomid vs TRT for fertility-preserving men: preserving axis versus direct replacement
Men who want symptom relief and future fertility often face a key fork: stimulate endogenous production with clomiphene or replace testosterone directly with...
ReadDaily tadalafil
Daily tadalafil is a medication or peptide considered in targeted protocols with clinician oversight.
ReadBone density and DEXA: who should test and when
Bone loss is usually silent until fracture. DEXA is one of the few tools that identifies risk early enough to act. This guide explains who should test, how...
ReadCreatine, protein, and the two supplements that actually moved your labs
The supplement aisle sells 200 ingredients. The list with real human evidence and clinically meaningful effect sizes is shorter than five. Here's the honest...
Read